Making Sense of Novartis and GlaxoSmithKline's Web of Deals - Presented by: The Aol. On Network

The pharmaceutical industry had a deluge of M&A activity on Tuesday as heavyweights Novartis and GlaxoSmithKline announced they were trading $20 billion worth of assets. Novartis will purchase GSK's oncology portfolio for $14.5 billion, strengthening its number two spot in the specialty. Meanwhile, GSK will purchase Novartis' vaccines unit for $5.25 billion. The two companies will also form a separate consumer healthcare business in which GSK will hold a 63.5 percent majority stake.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.81 0.23 ▼ 1.43%
JCP $ 8.50 0.62 ▼ 6.80%
AAPL $ 128.46 1.96 ▼ 1.50%
GE $ 25.99 0.10 ▲ 0.39%
S $ 5.12 0.35 ▲ 7.34%
PBR $ 6.63 0.34 ▲ 5.41%
CHK $ 16.68 0.52 ▼ 3.02%
TVIX $ 2.08 unch

As of 2/27/2015, 04:15 PM
More Most Active